Literature DB >> 25634160

A case series on the heightened autonomic response due to guanfacine and amphetamine interaction.

Edward C Gaiser1, David Matuskey, Evgenia Perkins, Cynthia D'Amico, Osama Abdelghany, Sherry A McKee, Kelly P Cosgrove.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25634160      PMCID: PMC4344400          DOI: 10.1097/JCP.0000000000000273

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  5 in total

Review 1.  VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.

Authors:  Lee E Eiden; Eberhard Weihe
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

2.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

Review 3.  Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.

Authors:  Amy F T Arnsten; Steven R Pliszka
Journal:  Pharmacol Biochem Behav       Date:  2011-02-02       Impact factor: 3.533

4.  Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings.

Authors:  Helen C Fox; Dongju Seo; Keri Tuit; Julie Hansen; Anne Kimmerling; Peter T Morgan; Rajita Sinha
Journal:  J Psychopharmacol       Date:  2012-01-09       Impact factor: 4.153

5.  Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Thomas J Spencer; Michael Greenbaum; Lawrence D Ginsberg; William Rory Murphy
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-10       Impact factor: 2.576

  5 in total
  3 in total

Review 1.  Alcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders.

Authors:  Sara K Blaine; Rajita Sinha
Journal:  Neuropharmacology       Date:  2017-02-01       Impact factor: 5.250

2.  The Effect of Treatment with Guanfacine, an Alpha2 Adrenergic Agonist, on Dopaminergic Tone in Tobacco Smokers: An [11C]FLB457 PET Study.

Authors:  Christine M Sandiego; David Matuskey; Meaghan Lavery; Erin McGovern; Yiyun Huang; Nabeel Nabulsi; Jim Ropchan; Marina R Picciotto; Evan D Morris; Sherry A McKee; Kelly P Cosgrove
Journal:  Neuropsychopharmacology       Date:  2017-09-25       Impact factor: 7.853

3.  Sex differences in amphetamine-induced dopamine release in the dorsolateral prefrontal cortex of tobacco smokers.

Authors:  Yasmin Zakiniaeiz; Ansel T Hillmer; David Matuskey; Nabeel Nabulsi; Jim Ropchan; Carolyn M Mazure; Marina R Picciotto; Yiyun Huang; Sherry A McKee; Evan D Morris; Kelly P Cosgrove
Journal:  Neuropsychopharmacology       Date:  2019-07-03       Impact factor: 7.853

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.